270 related articles for article (PubMed ID: 23633480)
1. Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factors.
Chettouh H; Fartoux L; Aoudjehane L; Wendum D; Clapéron A; Chrétien Y; Rey C; Scatton O; Soubrane O; Conti F; Praz F; Housset C; Rosmorduc O; Desbois-Mouthon C
Cancer Res; 2013 Jul; 73(13):3974-86. PubMed ID: 23633480
[TBL] [Abstract][Full Text] [Related]
2. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
3. Amphiregulin induces the alternative splicing of p73 into its oncogenic isoform DeltaEx2p73 in human hepatocellular tumors.
Castillo J; Goñi S; Latasa MU; Perugorría MJ; Calvo A; Muntané J; Bioulac-Sage P; Balabaud C; Prieto J; Avila MA; Berasain C
Gastroenterology; 2009 Nov; 137(5):1805-15.e1-4. PubMed ID: 19664633
[TBL] [Abstract][Full Text] [Related]
4. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor enhances alternative splicing of the Kruppel-like factor 6 (KLF6) tumor suppressor to promote growth through SRSF1.
Muñoz Ú; Puche JE; Hannivoort R; Lang UE; Cohen-Naftaly M; Friedman SL
Mol Cancer Res; 2012 Sep; 10(9):1216-27. PubMed ID: 22859706
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development.
Shilo A; Ben Hur V; Denichenko P; Stein I; Pikarsky E; Rauch J; Kolch W; Zender L; Karni R
RNA; 2014 Apr; 20(4):505-15. PubMed ID: 24572810
[TBL] [Abstract][Full Text] [Related]
7. RNA-binding protein CUGBP1 controls the differential INSR splicing in molecular subtypes of breast cancer cells and affects cell aggressiveness.
Huang G; Song C; Wang N; Qin T; Sui S; Obr A; Zeng L; Wood TL; Leroith D; Li M; Wu Y
Carcinogenesis; 2020 Sep; 41(9):1294-1305. PubMed ID: 31958132
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
Blanco FJ; Bernabeu C
Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
[TBL] [Abstract][Full Text] [Related]
9. The RNA-binding protein Sam68 modulates the alternative splicing of Bcl-x.
Paronetto MP; Achsel T; Massiello A; Chalfant CE; Sette C
J Cell Biol; 2007 Mar; 176(7):929-39. PubMed ID: 17371836
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous nuclear ribonucleoproteins A1 and A2 modulate expression of Tid1 isoforms and EGFR signaling in non-small cell lung cancer.
Chen CY; Jan CI; Pi WC; Wang WL; Yang PC; Wang TH; Karni R; Wang TC
Oncotarget; 2016 Mar; 7(13):16760-72. PubMed ID: 26919236
[TBL] [Abstract][Full Text] [Related]
11. Serum from Chronic Hepatitis B Patients Promotes Growth and Proliferation via the IGF-II/IGF-IR/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma Cells.
Ji Y; Wang Z; Chen H; Zhang L; Zhuo F; Yang Q
Cell Physiol Biochem; 2018; 47(1):39-53. PubMed ID: 29763915
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor isoform A favors tumor progression in human hepatocellular carcinoma by increasing stem/progenitor cell features.
Benabou E; Salamé Z; Wendum D; Lequoy M; Tahraoui S; Merabtene F; Chrétien Y; Scatton O; Rosmorduc O; Fouassier L; Fartoux L; Praz F; Desbois-Mouthon C
Cancer Lett; 2019 May; 450():155-168. PubMed ID: 30849481
[TBL] [Abstract][Full Text] [Related]
13. Use of high affinity insulin analogues to assess the functional relationships between insulin receptor trafficking, mitogenic signaling and mRNA expression in rat liver.
Authier F; Merlen C; Amessou M; Danielsen GM
Biochimie; 2004 Mar; 86(3):157-66. PubMed ID: 15134829
[TBL] [Abstract][Full Text] [Related]
14. Regulation of RAGE splicing by hnRNP A1 and Tra2β-1 and its potential role in AD pathogenesis.
Liu XY; Li HL; Su JB; Ding FH; Zhao JJ; Chai F; Li YX; Cui SC; Sun FY; Wu ZY; Xu P; Chen XH
J Neurochem; 2015 Apr; 133(2):187-98. PubMed ID: 25689357
[TBL] [Abstract][Full Text] [Related]
15. hnRNP A1 functions with specificity in repression of SMN2 exon 7 splicing.
Kashima T; Rao N; David CJ; Manley JL
Hum Mol Genet; 2007 Dec; 16(24):3149-59. PubMed ID: 17884807
[TBL] [Abstract][Full Text] [Related]
16. Deletion of serine/arginine-rich splicing factor 3 in hepatocytes predisposes to hepatocellular carcinoma in mice.
Sen S; Langiewicz M; Jumaa H; Webster NJ
Hepatology; 2015 Jan; 61(1):171-83. PubMed ID: 25132062
[TBL] [Abstract][Full Text] [Related]
17. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
[TBL] [Abstract][Full Text] [Related]
18. Transformation-associated changes in gene expression of alternative splicing regulatory factors in mouse fibroblast cells.
Maeda T; Furukawa S
Oncol Rep; 2001; 8(3):563-6. PubMed ID: 11295081
[TBL] [Abstract][Full Text] [Related]
19. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
20. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]